Germline Mutation Testing

Germline Mutation Testing is a clinical genetic analysis that identifies inherited pathogenic variants in DNA sequences associated with hereditary cancer syndromes by examining germline cells, typically derived from blood or saliva, to determine an individual’s predisposition to cancer.

1.3K

Publications

87K

Citations

10.3K

Authors

2.4K

Institutions

Publications per year

2017–2026

494

Variants

Germline Genetic Testing

Authors

10.3K

  1. ME
    Mark E. Robson

    Memorial Sloan Kettering Cancer Center, United States

    26 publications · 4.5K citations

    21

    h-index

  2. KO
    Kenneth Offit

    Memorial Sloan Kettering Cancer Center, United States

    26 publications · 4.8K citations

    19

    h-index

  3. ZK
    Zsofia K. Stadler

    Memorial Sloan Kettering Cancer Center, United States

    19 publications · 1.8K citations

    18

    h-index

  4. JE
    Judy E. Garber

    Dana-Farber Cancer Institute, United States

    22 publications · 3.1K citations

    17

    h-index

  5. DM
    Diana Mandelker

    Memorial Sloan Kettering Cancer Center, United States

    18 publications · 1.3K citations

    16

    h-index

1–5 of 10.3K

Venues

  1. Journal of Clinical Oncology

    57 publications · 12.3K citations

    42

    h-index

  2. Cancer

    38 publications · 2.9K citations

    27

    h-index

  3. Journal of Medical Genetics

    JMG · 38 publications · 3.1K citations

    26

    h-index

  4. The Journal of Clinical Endocrinology & Metabolism

    JCEM · 27 publications · 2.4K citations

    24

    h-index

  5. Human Mutation

    32 publications · 2.1K citations

    23

    h-index

1–5